MyAverix Finance
NS · Pharmaceuticals
Eris Lifesciences Ltd (ERIS)
Pharmaceuticals & Biotechnology
Eris Lifesciences Ltd (ERIS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $203.66B, P/E ratio is 83.43, net margin is 12.3%, dividend yield is 0.49%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ERIS
Eris Lifesciences Ltd (ERIS) — FAQ
What is Eris Lifesciences Ltd's market cap?
Eris Lifesciences Ltd (ERIS) has a reported market cap of $203.66B (data as of 2026-07-10).
What is ERIS's P/E ratio?
The price-to-earnings (P/E) ratio for Eris Lifesciences Ltd (ERIS) is 83.43 (data as of 2026-07-10).
Does Eris Lifesciences Ltd pay a dividend?
Eris Lifesciences Ltd (ERIS) shows a reported dividend yield of 0.49%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Eris Lifesciences Ltd in?
Eris Lifesciences Ltd (ERIS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ERIS listed on?
ERIS is listed on NS.
What is Eris Lifesciences Ltd's net margin?
Eris Lifesciences Ltd (ERIS) reports a net margin of 12.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.